<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-125518</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Hemophagocytic lymphohistiocytosis associated with viral infections: diagnostic challenges and therapeutic dilemmas</dc:title>
<dc:description xml:lang="en">Hemophagocytic lymphohistiocytosis is a frequently fatal clinicopathologic syndrome in which an uncontrolled and ineffective immune response leads to severe hyperinflammation. It may occur as either a familial disorder or a sporadic condition in association with a variety of triggers: infections, malignancies, autoimmune diseases, and acquired immune deficiencies. However, the most consistent association is with viral infections, especially Epstein-Barr virus. The main clinical features are fever, liver dysfunction, coagulation abnormalities and pancytopenia. Early diagnosis and treatment are important to reducing mortality, but the diagnosis is difficult because of the rarity of the syndrome and the lack of specificity of the clinical findings. Treatment should be directed towards treating the underlying disease and to suppressing the exaggerated inflammatory response through the use of immunosuppressive agents (AU)</dc:description>
<dc:creator>Mostaza-Fernández, J. L</dc:creator>
<dc:creator>Ruiz de Morales, J. M. G</dc:creator>
<dc:creator>Guerra Laso, J</dc:creator>
<dc:creator>Carriedo Ule, D</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La linfohistiocitosis hemofagocítica es un síndrome clinicopatológico de evolución potencialmente fatal, en el que una respuesta inmune no controlada e ineficaz conduce a hiperinflamación. Puede aparecer como una enfermedad familiar o esporádica, asociado a diferentes factores desencadenantes: infecciones, neoplasias, enfermedades autoinmunes o inmunodeficiencias adquiridas, pero la asociación más consistente es con infecciones virales, especialmente el virus de Epstein-Barr. Las principales características clínicas son fiebre, disfunción hepática, coagulopatía y pancitopenia. El diagnóstico es difícil debido a la rareza de este síndrome y a la falta de especificidad de los hallazgos clínicos, sin embargo, un diagnóstico y tratamiento precoces son importantes para disminuir la mortalidad. El tratamiento debe ser dirigido al control de la enfermedad subyacente y a suprimir la respuesta inflamatoria exagerada mediante el uso de inmunosupresores (AU)</dc:description>
<dc:source>Rev Clin Esp;214(6): 320-327, ago.-sept. 2014.</dc:source>
<dc:identifier>ibc-125518</dc:identifier>
<dc:title xml:lang="es">Linfohistiocitosis hemofagocítica asociada a infecciones virales: reto diagnóstico y dilema terapéutico</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d1805^s22012</dc:subject>
<dc:subject>^d21079^s22016</dc:subject>
<dc:subject>^d52798</dc:subject>
<dc:subject>^d21079^s22047</dc:subject>
<dc:subject>^d10385^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d50506^s22016</dc:subject>
<dc:subject>^d33755^s22012</dc:subject>
<dc:subject>^d50506^s22047</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d50506^s22012</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d33755^s22016</dc:subject>
<dc:subject>^d50506^s22032</dc:subject>
<dc:subject>^d5444^s22012</dc:subject>
<dc:subject>^d7344^s22073</dc:subject>
<dc:subject>^d8281^s22012</dc:subject>
<dc:subject>^d5444^s22027</dc:subject>
<dc:subject>^d21079^s22012</dc:subject>
<dc:subject>^d21079^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>201409</dc:date>
</metadata>
</record>
</ibecs-document>
